Sale!

Her-2 Neu Ca Breast Test Cost

Original price was: 3,200 د.إ.Current price is: 2,400 د.إ.

-25%

The “Her-2 Neu Ca Breast Test” is a diagnostic procedure conducted to evaluate the presence of the HER2 protein in breast cancer cells. HER2 (Human Epidermal Growth Factor Receptor 2) is a gene that can play a role in the development of breast cancer. Its overexpression or amplification in breast cancer cells can influence the behavior of the cancer, including its growth and spread. Testing for HER2 status is crucial as it helps in determining the most effective treatment options for patients. Treatments that specifically target HER2-positive breast cancers are available and can significantly improve outcomes for patients with this type of cancer.

The test is performed on a sample of breast cancer tissue, usually obtained through a biopsy or surgery. It involves specialized techniques to measure the amount of HER2 protein or the number of HER2 genes in the cancer cells. The results of the HER-2 Neu Ca Breast Test can classify breast cancer as HER2-positive or HER2-negative, guiding oncologists in tailoring treatment plans that are more personalized and potentially more effective.

In the United Arab Emirates, the HER-2 Neu Ca Breast Test is available at DNA Labs UAE, a leading diagnostic facility known for its advanced testing capabilities and commitment to patient care. The cost of the test at DNA Labs UAE is 2400 AED, reflecting the intricate processes and specialized technology required to accurately assess HER2 status. Patients opting for this test at DNA Labs UAE can expect reliable results that are critical for making informed decisions about their breast cancer treatment options.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Her-2 Neu Ca Breast Test

Test Name: Her-2 Neu Ca Breast Test

Components: Paraffin embedded tissue blocks

Price: 2400.0 AED

Sample Condition: Tumor tissue

Report Delivery: 7-8 days

Method: FISH

Test Type: Genetics

Doctor: Oncology

Test Department:

Pre Test Information: Her-2 Neu (Ca Breast) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details:

HER2 (human epidermal growth factor receptor 2) is a protein that is found on the surface of certain cancer cells, including breast cancer cells. The HER2 gene produces this protein, and when it is overexpressed or amplified, it can lead to uncontrolled cell growth and division, contributing to the development and progression of breast cancer.

HER2-positive breast cancer refers to breast cancer cells that have an overexpression or amplification of the HER2 protein. This type of breast cancer tends to be more aggressive and fast-growing compared to HER2-negative breast cancer. However, HER2-positive breast cancer can be targeted with specific treatments that block the HER2 protein or its signaling pathways, such as HER2-targeted therapies like trastuzumab (Herceptin) and pertuzumab (Perjeta).

Testing for HER2 status is an important part of diagnosing and treating breast cancer. It involves analyzing a breast cancer tissue sample to determine whether the HER2 protein is overexpressed or amplified. This information helps guide treatment decisions and can help predict the response to HER2-targeted therapies.

Test Name Her-2 Neu Ca Breast Test
Components Paraffin embedded tissue blocks
Price 2400.0 AED
Sample Condition Tumor tissue
Report Delivery 7-8 days
Method FISH
Test type Genetics
Doctor Oncology
Test Department:
Pre Test Information Her-2 Neu (Ca Breast) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

HER2 (human epidermal growth factor receptor 2) is a protein that is found on the surface of certain cancer cells, including breast cancer cells. The HER2 gene produces this protein, and when it is overexpressed or amplified, it can lead to uncontrolled cell growth and division, contributing to the development and progression of breast cancer.

HER2-positive breast cancer refers to breast cancer cells that have an overexpression or amplification of the HER2 protein. This type of breast cancer tends to be more aggressive and fast-growing compared to HER2-negative breast cancer. However, HER2-positive breast cancer can be targeted with specific treatments that block the HER2 protein or its signaling pathways, such as HER2-targeted therapies like trastuzumab (Herceptin) and pertuzumab (Perjeta).

Testing for HER2 status is an important part of diagnosing and treating breast cancer. It involves analyzing a breast cancer tissue sample to determine whether the HER2 protein is overexpressed or amplified. This information helps guide treatment decisions and can help predict the response to HER2-targeted therapies.